Molecular portraits of human breast tumours

Cluster analysis and display of genome-wide expression patterns

Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184

Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice

Elkabets, M., Gifford, A. M., Scheel, C., Nilsson, B., Reinhardt, F., Bray, M.-A., Carpenter, A. E., Jirström, K., Magnusson, K., Ebert, B. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43757 · Cited by 201

Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin α5β1 and Fibronectin

Nam, J.-M., Onodera, Y., Bissell, M. J., & Park, C. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2319 · Cited by 196

Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer

Gu, Y., Yang, R., Zhang, Y., Guo, M., Takehiro, K., Zhan, M., Yang, L., & Wang, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00239-2 · Cited by 184

CD151 Accelerates Breast Cancer by Regulating α6 Integrin Function, Signaling, and Molecular Organization

Yang, X. H., Richardson, A. L., Torres-Arzayus, M. I., Zhou, P., Sharma, C., Kazarov, A. R., Andzelm, M. M., Strominger, J. L., Brown, M., & Hemler, M. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2949 · Cited by 183

In Vivo Regulation of Human Skeletal Muscle Gene Expression by Thyroid Hormone

Clément, K., Viguerie, N., Diehn, M., Alizadeh, A., Barbe, P., Thalamas, C., Storey, J. D., Brown, P. O., Barsh, G. S., & Langin, D. (2002) · Genome Research · doi:10.1101/gr.207702 · Cited by 169

Radiogenomic Analysis to Identify Imaging Phenotypes Associated with Drug Response Gene Expression Programs in Hepatocellular Carcinoma

Kuo, M. D., Gollub, J., Sirlin, C. B., Ooi, C., & Chen, X. (2007) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2007.04.031 · Cited by 168

Recent advances of highly selective CDK4/6 inhibitors in breast cancer

Xu, H., Yu, S., Liu, Q., Yuan, X., Mani, S., Pestell, R. G., & Wu, K. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0467-2 · Cited by 168

Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival

Tang, W., Zhou, M., Dorsey, T. H., Prieto, D. A., Wang, X. W., Ruppin, E., Veenstra, T. D., & Ambs, S. (2018) · Genome Medicine · doi:10.1186/s13073-018-0602-x · Cited by 162

Effect of ASCO/CAP guidelines for determining ER status on molecular subtype

Deyarmin, B., Kane, J. L., Valente, A. L., van Laar, R., Gallagher, C., Shriver, C. D., & Ellsworth, R. E. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2588-8 · Cited by 149

A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2-positive metastatic breast cancer

Lok, S. W., Whittle, J. R., Vaillant, F., Teh, C. E., Lo, L. L., Policheni, A. N., Bergin, A. R. T., Desai, J., Ftouni, S., Gandolfo, L. C., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1151 · Cited by 148

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

Merino, D., Weber, T. S., Serrano, A., Vaillant, F., Liu, K., Pal, B., Di Stefano, L., Schreuder, J., Lin, D., Chen, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08595-2 · Cited by 145

Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance

Mohammed, R. A. A., Ellis, I. O., Mahmmod, A. M., Hawkes, E. C., Green, A. R., Rakha, E. A., & Martin, S. G. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.4 · Cited by 145

MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes

Fujii, S., Tokita, K., Wada, N., Ito, K., Yamauchi, C., Ito, Y., & Ochiai, A. (2011) · Oncogene · doi:10.1038/onc.2011.118 · Cited by 137

Predictability of human differential gene expression

Crow, M., Lim, N., Ballouz, S., Pavlidis, P., & Gillis, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802973116 · Cited by 117

Relapsed Classic E-Cadherin ( CDH1 )–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 ( ERBB2 ) Gene Mutations

Ross, J. S., Wang, K., Sheehan, C. E., Boguniewicz, A. B., Otto, G., Downing, S. R., Sun, J., He, J., Curran, J. A., Ali, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0295 · Cited by 135

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy

Andre, F., & Pusztai, L. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0636 · Cited by 134

Interferons and the immunogenic effects of cancer therapy

Minn, A. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.09.007 · Cited by 130

FOXA1 mutations reveal distinct chromatin profiles and influence therapeutic response in breast cancer

Arruabarrena-Aristorena, A., Maag, J. L. V., Kittane, S., Cai, Y., Karthaus, W. R., Ladewig, E., Park, J., Kannan, S., Ferrando, L., Cocco, E., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.003 · Cited by 130

TRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin Cortex

Lee, W. H., Choong, L. Y., Mon, N. N., Lu, S., Lin, Q., Pang, B., Yan, B., Krishna, V. S. R., Singh, H., Tan, T. Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27903 · Cited by 125

Human transcriptome array for high-throughput clinical studies

Xu, W., Seok, J., Mindrinos, M. N., Schweitzer, A. C., Jiang, H., Wilhelmy, J., Clark, T. A., Kapur, K., Xing, Y., Faham, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019753108 · Cited by 124

Regulation of Tcf7l1 DNA Binding and Protein Stability as Principal Mechanisms of Wnt/β-Catenin Signaling

Shy, B. R., Wu, C.-I., Khramtsova, G. F., Zhang, J. Y., Olopade, O. I., Goss, K. H., & Merrill, B. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.001 · Cited by 124

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations: Table 1

Wilson, J. R. F., Bateman, A. C., Hanson, H., An, Q., Evans, G., Rahman, N., Jones, J. L., & Eccles, D. M. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.078113 · Cited by 122

Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review

Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122

An approach for normalization and quality control for NanoString RNA expression data

Bhattacharya, A., Hamilton, A. M., Furberg, H., Pietzak, E., Purdue, M. P., Troester, M. A., Hoadley, K. A., & Love, M. I. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa163 · Cited by 122

Epigenetics as a Therapeutic Target in Breast Cancer

Connolly, R., & Stearns, V. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9263-3 · Cited by 117

Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer

Lu, Y., & Liu, W. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00913 · Cited by 119

The Roles of MicroRNAs in Breast Cancer

Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2015) · Cancers · doi:10.3390/cancers7020598 · Cited by 116

Machine learning in bioinformatics: A brief survey and recommendations for practitioners

Bhaskar, H., Hoyle, D. C., & Singh, S. (2006) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2005.09.002 · Cited by 109

Immunotherapy in breast cancer: Current status and future directions

(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2019.03.006 · Cited by 109

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

Al-Ejeh, F., Simpson, P. T., Sanus, J. M., Klein, K., Kalimutho, M., Shi, W., Miranda, M., Kutasovic, J., Raghavendra, A., Madore, J., et al. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.14 · Cited by 107

Subtypes of familial breast tumours revealed by expression and copy number profiling

kConFab Investigators, Waddell, N., Arnold, J., Cocciardi, S., da Silva, L., Marsh, A., Riley, J., Johnstone, C. N., Orloff, M., Assie, G., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0653-1 · Cited by 99

Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer

Brauer, H. A., Makowski, L., Hoadley, K. A., Casbas-Hernandez, P., Lang, L. J., Romàn-Pèrez, E., D'Arcy, M., Freemerman, A. J., Perou, C. M., & Troester, M. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2123 · Cited by 96

Transcriptomic Biomarkers for the Accurate Diagnosis of Myocarditis

Heidecker, B., Kittleson, M. M., Kasper, E. K., Wittstein, I. S., Champion, H. C., Russell, S. D., Hruban, R. H., Rodriguez, E. R., Baughman, K. L., & Hare, J. M. (2011) · Circulation · doi:10.1161/circulationaha.110.002857 · Cited by 97

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Mateo, J., Ong, M., Tan, D. S. P., Gonzalez, M. A., & de Bono, J. S. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.177 · Cited by 96

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification

Dunne, P. D., Alderdice, M., O'Reilly, P. G., Roddy, A. C., McCorry, A. M. B., Richman, S., Maughan, T., McDade, S. S., Johnston, P. G., Longley, D. B., et al. (2017) · Nature Communications · doi:10.1038/ncomms15657 · Cited by 94

Atezolizumab for the treatment of breast cancer

Reddy, S. M., Carroll, E., & Nanda, R. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1732211 · Cited by 94

An integrative deep learning framework for classifying molecular subtypes of breast cancer

Mohaiminul Islam, M., Huang, S., Ajwad, R., Chi, C., Wang, Y., & Hu, P. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.005 · Cited by 90

The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients

Hurley, J., Reis, I. M., Rodgers, S. E., Gomez-Fernandez, C., Wright, J., Leone, J. P., Larrieu, R., & Pegram, M. D. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2497-y · Cited by 83

HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer

Mahara, S., Lee, P. L., Feng, M., Tergaonkar, V., Chng, W. J., & Yu, Q. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602079113 · Cited by 87

Alteration of Cellular Behavior and Response to PI3K Pathway Inhibition by Culture in 3D Collagen Gels

Fallica, B., Maffei, J. S., Villa, S., Makin, G., & Zaman, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048024 · Cited by 84

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

Gass, P., Lux, M. P., Rauh, C., Hein, A., Bani, M. R., Fiessler, C., Hartmann, A., Häberle, L., Pretscher, J., Erber, R., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4925-1 · Cited by 83

Role of dietary bioactive natural products in estrogen receptor-positive breast cancer

Bak, M. J., Das Gupta, S., Wahler, J., & Suh, N. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.03.001 · Cited by 80

A Machine Learning Classifier for Assigning Individual Patients With Systemic Sclerosis to Intrinsic Molecular Subsets

Franks, J. M., Martyanov, V., Cai, G., Wang, Y., Li, Z., Wood, T. A., & Whitfield, M. L. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40898 · Cited by 80

Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells

Bower, J. J., Vance, L. D., Psioda, M., Smith-Roe, S. L., Simpson, D. A., Ibrahim, J. G., Hoadley, K. A., Perou, C. M., & Kaufmann, W. K. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0009-7 · Cited by 76

Targeting the glucocorticoid receptor in breast and prostate cancers

Kach, J., Conzen, S. D., & Szmulewitz, R. Z. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7531 · Cited by 74

The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation

Tabach, Y., Milyavsky, M., Shats, I., Brosh, R., Zuk, O., Yitzhaky, A., Mantovani, R., Domany, E., Rotter, V., & Pilpel, Y. (2005) · Molecular Systems Biology · doi:10.1038/msb4100030 · Cited by 72

BET Bromodomain Proteins as Cancer Therapeutic Targets

Shu, S., & Polyak, K. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030908 · Cited by 72

A microRNA Signature Associated with Early Recurrence in Breast Cancer

Pérez-Rivas, L. G., Jerez, J. M., Carmona, R., de Luque, V., Vicioso, L., Claros, M. G., Viguera, E., Pajares, B., Sánchez, A., Ribelles, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091884 · Cited by 67

Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer

Sun, X., Tang, H., Chen, Y., Chen, Z., Hu, Z., Cui, Z., Tao, Y., Yuan, J., Fu, Y., Zhuang, Z., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00535-w · Cited by 66

Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers

Coutant, C., Rouzier, R., Qi, Y., Lehmann-Che, J., Bianchini, G., Iwamoto, T., Hortobagyi, G. N., Symmans, W. F., Uzan, S., Andre, F., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1045 · Cited by 64

Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer

Légaré, S., & Basik, M. (2016) · Molecular Endocrinology · doi:10.1210/me.2016-1072 · Cited by 63

Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative

Rydén, L., Loman, N., Larsson, C., Hegardt, C., Vallon-Christersson, J., Malmberg, M., Lindman, H., Ehinger, A., Saal, L. H., & Borg, Å. (2018) · British Journal of Surgery · doi:10.1002/bjs.10741 · Cited by 62

Hereditary breast cancer: From molecular pathology to tailored therapies

Tan, D. S. P., Marchiò, C., & Reis-Filho, J. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.057950 · Cited by 60

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

Mundi, P. S., Dela Cruz, F. S., Grunn, A., Diolaiti, D., Mauguen, A., Rainey, A. R., Guillan, K. C., Siddiquee, A., You, D., Realubit, R., et al. (2021) · doi:10.1101/2021.10.03.462951 · Cited by 51

Targeting triple-negative breast cancers with the Smac-mimetic birinapant

Lalaoui, N., Merino, D., Giner, G., Vaillant, F., Chau, D., Liu, L., Kratina, T., Pal, B., Whittle, J. R., Etemadi, N., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0541-0 · Cited by 51

Identification of synergistic drug combinations using breast cancer patient-derived xenografts

Turner, T. H., Alzubi, M. A., & Harrell, J. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-58438-0 · Cited by 50

Laser direct-write onto live tissues: a novel model for studying cancer cell migration

Burks, H. E., Phamduy, T. B., Azimi, M. S., Saksena, J., Burow, M. E., Collins‐Burow, B. M., Chrisey, D. B., & Murfee, W. L. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25363 · Cited by 48

Small nucleolar RNA and its potential role in breast cancer – A comprehensive review

Dsouza, V. L., Adiga, D., Sriharikrishnaa, S., Suresh, P. S., Chatterjee, A., & Kabekkodu, S. P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188501 · Cited by 48

Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity

Martini, R., Newman, L., & Davis, M. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10087-x · Cited by 46

HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer

Gogiashvili, M., Nowacki, J., Hergenröder, R., Hengstler, J. G., Lambert, J., & Edlund, K. (2019) · Metabolites · doi:10.3390/metabo9020019 · Cited by 44

Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis

Rondón-Lagos, M., Verdun Di Cantogno, L., Marchiò, C., Rangel, N., Payan-Gomez, C., Gugliotta, P., Botta, C., Bussolati, G., Ramírez-Clavijo, S. R., Pasini, B., et al. (2014) · Molecular Cytogenetics · doi:10.1186/1755-8166-7-8 · Cited by 43

An “elite hacker”: breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity

Boudreau, A., van't Veer, L. J., & Bissell, M. J. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20880 · Cited by 43

Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy

Eelen, G., Vanden Bempt, I., Verlinden, L., Drijkoningen, M., Smeets, A., Neven, P., Christiaens, M. R., Marchal, K., Bouillon, R., & Verstuyf, A. (2008) · Oncogene · doi:10.1038/onc.2008.51 · Cited by 41

GO-PCA: An Unsupervised Method to Explore Gene Expression Data Using Prior Knowledge

Wagner, F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143196 · Cited by 35

Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

Ayoub, N., Al-Shami, K., Alqudah, M. A. Y., & Mhaidat, N. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s148604 · Cited by 38

The regulatory role of miRNAs on VDR in breast cancer

Singh, T., & Adams, B. D. (2017) · Transcription · doi:10.1080/21541264.2017.1317695 · Cited by 37

Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes

Chun, Y. S., Mizuno, T., Cloyd, J. M., Ha, M. J., Omichi, K., Tzeng, C.-W. D., Aloia, T. A., Ueno, N. T., Kuerer, H. M., Barcenas, C. H., et al. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.03.214 · Cited by 32

Molecular mechanism of triple‑negative breast cancer‑associated BRCA1 and the identification of signaling pathways

Qi, F., Qin, W., & Zang, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.9884 · Cited by 32

Phenotype prediction from single-cell RNA-seq data using attention-based neural networks

Mao, Y., Lin, Y.-Y., Wong, N. K. Y., Volik, S., Sar, F., Collins, C., & Ester, M. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae067 · Cited by 31

Tissue preparation for laser capture microdissection and RNA extraction from fresh frozen breast tissue

Morrogh, M., Olvera, N., Bogomolniy, F., Borgen, P. I., & King, T. A. (2007) · BioTechniques · doi:10.2144/000112497 · Cited by 29

Presence of Insulin-Like Growth Factor Binding Proteins Correlates With Tumor-Promoting Effects of Matrix Metalloproteinase 9 in Breast Cancer

Park, J.-H., Rasch, M. G., Qiu, J., Lund, I. K., & Egeblad, M. (2015) · Neoplasia · doi:10.1016/j.neo.2015.04.003 · Cited by 29

Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence

Wang, Y. K., Print, C. G., & Crampin, E. J. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-102 · Cited by 28

A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker

Bii, V. M., Rae, D. T., & Trobridge, G. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6232 · Cited by 28

A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosis

Lin, T., Gu, J., Qu, K., Zhang, X., Ma, X., Miao, R., Xiang, X., Fu, Y., Niu, W., She, J., et al. (2018) · Aging · doi:10.18632/aging.101563 · Cited by 26

Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness

Joe, N. S., Godet, I., Milki, N., Ain, N. U. I., Oza, H. H., Riggins, G. J., & Gilkes, D. M. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01591-3 · Cited by 24

Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer

Sparano, J. A., Goldstein, L. J., Childs, B. H., Shak, S., Brassard, D., Badve, S., Baehner, F. L., Bugarini, R., Rowley, S., Perez, E. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3357 · Cited by 22

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer

Upreti, M., Jyoti, A., Johnson, S. E., Swindell, E. P., Napier, D., Sethi, P., Chan, R., Feddock, J. M., Weiss, H. L., O’Halloran, T. V., et al. (2106) · Oncotarget · doi:10.18632/oncotarget.9490 · Cited by 21

Evolution of chromosome-arm aberrations in breast cancer through genetic network rewiring

Kuzmin, E., Baker, T. M., Lesluyes, T., Monlong, J., Abe, K. T., Coelho, P. P., Schwartz, M., Del Corpo, J., Zou, D., Morin, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113988 · Cited by 20

mTOR Inhibitors, a New Era for Metastatic Luminal HER2-Negative Breast Cancer? A Systematic Review and a Meta-Analysis of Randomized Trials

Rotundo, M. S., Galeano, T., Tassone, P., & Tagliaferri, P. (2016) · Oncotarget · doi:10.18632/oncotarget.7446 · Cited by 18

Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61

BAUERSCHMITZ, G., HÜCHEL, S., GALLWAS, J., & GRÜNDKER, C. (2023) · Cancer Genomics - Proteomics · doi:10.21873/cgp.20403 · Cited by 11

The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes

Mills, M., Liveringhouse, C., Lee, F., Nanda, R. H., Ahmed, K. A., Washington, I. R., Thapa, R., Fridley, B. L., Blumencranz, P., Extermann, M., et al. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.08.007 · Cited by 7

Proteome-wide copy-number estimation from transcriptomics

Sweatt, A. J., Griffiths, C. D., Groves, S. M., Paudel, B. B., Wang, L., Kashatus, D. F., & Janes, K. A. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00064-3 · Cited by 5

The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression

Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos-Hoff, M. H., Petersen, O. W., et al. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.02.004 · Cited by 2